赛升药业：2025年前三季度净利润同比增长152.81%

Core Insights - The company reported a revenue of 309 million yuan for the first three quarters of 2025, representing a year-on-year decline of 4.41% [1] - The net profit attributable to shareholders increased to 52 million yuan, showing a significant year-on-year growth of 152.81% [1] - Basic earnings per share reached 0.11 yuan, reflecting a year-on-year increase of 155% [1]